Table 1.

Demographic and Baseline Clinical Features

Characteristic	Normal GE (N=25)	Rapid GE (N=18)	Delayed GE (N=17)
Age, yrs	48 ± 4	49 ± 4	41 ± 4
Sex, number of women (%)	18 (72%)	8 (44%)	12(71%)
BMI kg/m2	27.4 ± 1.4	28.6 ± 1.6	24 ± 1.4
Diabetes mellitus, number of patients	7 (28%)	8 (44%)	6 (35%)
HbA1c level, %	7.7 ± 0.4	7.1 ± 0.5	8.2 ± 0.7
FDA NVFP* composite score	1.8 ± 0.2	2.4 ± 0.3	2.9 ± 0.3
GCSI Total#	0.9 ± 0.1	1.7 ± 0.2	2 ± 0.2
Anxiety (HAD score ≥ 11), Number of patients	7	7	1
Depression (HAD score ≥ 11), Number of patients	4	8	3

All values are Mean ± SEM unless stated otherwise

^*FDA NVFP score is the average of nausea, vomiting, fullness, and pain scores in PAGI-SYM questionnaire

^#GCSI Total is the average of satiety, nausea/vomiting/regurgitation and bloating sub-scores obtained from the PAGI-SYM questionnaire